Ignite Creation Date:
2024-05-06 @ 3:34 PM
Last Modification Date:
2024-10-26 @ 1:52 PM
Study NCT ID:
NCT04676516
Status:
COMPLETED
Last Update Posted:
2022-10-25
First Post:
2020-07-28
Brief Title:
A Phase II Window of Opportunity Trial of PRMT5 Inhibitor GSK3326595 in Early Stage Breast Cancer
Sponsor:
Ottawa Hospital Research Institute
Organization:
Ottawa Hospital Research Institute
Organization Data
Organization:
Ottawa Hospital Research Institute
Class:
OTHER
Study ID:
OTT-19-06
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ottawa Hospital Research Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Hamilton Health Sciences Corporation | OTHER |
| Ontario Institute for Cancer Research | OTHER |
| GlaxoSmithKline | INDUSTRY |
| London Regional Cancer Program Canada | OTHER |